Metabolism and glioma therapy
- PMID: 25054292
- PMCID: PMC6178275
- DOI: 10.2217/cns.12.9
Metabolism and glioma therapy
Conflict of interest statement
References
-
- Niyazi M, Siefert A, Schwarz SB, et al. Therapeutic options for recurrent malignant glioma. Radiother. Oncol. 2011;98(1):1–14. - PubMed
-
- Nicholas MK, Lukas RV, Chmura S, Yamini B, Lesniak M, Pytel P. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. Semin. Oncol. 2011;38(2):243–253. - PubMed
-
- Roesler R, Brunetto AT, Abujamra AL, de Farias CB, Brunetto AL, Schwartsmann G. Current and emerging molecular targets in glioma. Expert Rev. Anticancer Ther. 2010;10(11):1735–1751. - PubMed
-
- Arribas AL, Menendez LA, Yaya TR. Glioblastoma: changing expectations? Clin. Transl. Oncol. 2011;13(4):240–248. - PubMed
-
- Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. - PubMed
-
▪ Discussion of the ‘Warburg hypothesis’.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical